Reuters logo
BRIEF-FDA approves treatment for metastatic merkel cell carcinoma
2017年3月23日 / 晚上6点29分 / 7 个月前

BRIEF-FDA approves treatment for metastatic merkel cell carcinoma

March 23 (Reuters) - U.S. FDA:

* Granted accelerated approval to Bavencio for treatment of adults, pediatric patients 12 years and older with metastatic merkel cell carcinoma

* Further clinical trials are required to confirm Bavencio’s clinical benefit Source text - (bit.ly/2nN2hTA) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below